Wegovy Guide
Wegovy is the brand-name formulation of semaglutide, approved for long-term weight management, for lowering cardiovascular risk, and (since August 2025) for treating noncirrhotic MASH with liver fibrosis. Developed by Novo Nordisk, it is available as a once-weekly subcutaneous injection (0.25–2.4 mg, or up to 7.2 mg Wegovy HD for weight reduction) and, since December 2025, a once-daily oral tablet, 1.5–25 mg, carrying the adult weight reduction and cardiovascular risk reduction indications.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
At a Glance
| Generic Name | Semaglutide |
| Brand Names | Wegovy |
| FDA Status | FDA-approved for chronic weight management in adults with obesity or overweight with comorbidity (June 2021); cardiovascular risk reduction in adults with established CVD (March 2024); weight reduction in pediatric patients aged 12+ (December 2022); noncirrhotic MASH with moderate-to-advanced liver fibrosis in adults (August 2025, accelerated approval); and an oral tablet form for cardiovascular risk reduction or weight reduction in adults (December 2025), alongside the original injection[1] |
| Approval Date | June 4, 2021[1] |
How does Wegovy work?
Wegovy mimics the GLP-1 hormone to signal fullness to the brain, slow stomach emptying, and reduce overall caloric intake. The injection reaches a maintenance dose of 1.7–2.4 mg weekly (up to 7.2 mg for weight reduction if more loss is needed); the 2026-added oral tablet reaches a 25 mg once-daily maintenance dose through its own 90-day titration — both deliver the same active ingredient, semaglutide, just via a different route and schedule.[2]
Dosing Schedule — Injection
Wegovy uses a gradual dose escalation to minimize side effects. Always follow your prescriber's guidance and the current FDA label[1].
Dosing Schedule — Tablet (approved December 2025)
What side effects does Wegovy cause?
Common: nausea (44%), diarrhea (30%), vomiting (24%), constipation (24%), abdominal pain (20%), headache, fatigue. The pattern over time: worst while the dose is being stepped up, largely settled by week 4 to 8. Serious (rare): pancreatitis, gallstones, kidney injury, heart rate increase. The suicidal behavior and ideation section was removed from the label in February 2026 after large studies found no increase.[1][2]
Nothing above is the full list. Your prescriber can give you the complete safety picture, and every adverse reaction on record sits in the current FDA prescribing information[1].
Clinical Trial Results
Two trials carry Wegovy. STEP-1 put mean body-weight loss at 14.9% over 68 weeks — roughly 34 lbs — against 2.4% on placebo. SELECT (N=17,604) then took obese patients with established CVD and cut major adverse cardiovascular events by 20%.[2][3][4]
Where can you get Wegovy?
Sellers in our register that will dispense semaglutide, or a compounded version of it, after an online consultation — shipped to your door.
altRX
Best for: compounded semaglutide from $89/month at the same price at every dose
Editorial score · methodology
Editorial score · methodology
RxSpan MD
Best for: knowing which pharmacy fills the vial: it names Belmar Pharmacy
Editorial score · methodology
Editorial score · methodology
AgelessRx
Best for: microdosed compounded GLP-1s from a longevity clinic, or brand Wegovy at manufacturer pricing plus monitoring
Editorial score · methodology
Wellorithm
Best for: compounded semaglutide at a flat $247 every 28 days, any dose
Editorial score · methodology
How much does Wegovy cost?
58 sellers in the register publish a price; the lowest starts at $100 a month, checked November 2026. What each one charges to start, cheapest at the top. Compounded semaglutide from state-licensed 503A pharmacies is legal under federal compounding law when made for an individual patient[5], and the rules loosen further, to include bulk compounding by 503B outsourcing facilities, only while a molecule sits on the FDA Drug Shortage List[6]. An FSA or HSA will generally cover either kind of prescription, compounded or branded, under IRS Publication 502[7]. What you actually pay moves with your dose and with whatever promotion happens to be running.
| Provider | Starting Price | Link | |
|---|---|---|---|
| Oak | brand | $100/mo | Visit |
| Amazon One Medical | brand | $149/mo + visit fee | Visit |
| Heally | brand | $149/mo | Visit |
| Healthspan | brand | $149/mo + membership | Visit |
| Hims | brand | $149/mo + membership | Visit |
| Imbue Health | brand | $149/mo + membership | Visit |
| Intermountain Health On-Demand Weight Loss | brand | $149/mo + consult fee | Visit |
| Knownwell | brand | $149/mo + visit fee | Visit |
| médetone | brand | $149/mo + membership | Visit |
| Mochi Health | brand | $149/mo + membership | Visit |
Show all 58 Wegovy sellersShowing all 58 sellers
| NovoCare Pharmacy | brand | $149/mo | Visit |
| PreventiveMD | brand | $149/mo | Visit |
| Ro | brand | $149/mo + membership | Visit |
| Sesame Care | brand | $149/mo + care fee | Visit |
| ShedRx | brand | $149/mo + membership | Visit |
| Walgreens Weight Management | brand | $149/mo + visit fee | Visit |
| WeightWatchers Clinic | brand | $149/mo + membership | Visit |
| ZipHealth | brand | $149/mo + fees | Visit |
| Aspire Health | brand | $199/mo + care fee | Visit |
| Found | brand | $199/mo + membership | Visit |
| GOAL.MD | brand | $244/mo | Visit |
| Alloy | brand | $248/mo | Visit |
| Phoenix NP | brand | $248/mo | Visit |
| SkinnyRx | brand | $248/mo | Visit |
| Maximus | brand | $249.99/mo | Visit |
| Healthicare | brand | $268.68/mo | Visit |
| Good Girl Rx | brand | $297/mo | Visit |
| LifeMD | brand | $298/mo | Visit |
| Rex MD | brand | $349/mo | Visit |
| WePeptideRx | brand | $399/mo | Visit |
| AgelessRx | brand | $414/mo | Visit |
| Näky | brand | $424/mo + membership | Visit |
| Klinic | brand | $499/mo | Visit |
| Pallas Health | brand | $499/mo | Visit |
| Wellorithm | brand | $899/mo, prepaid | Visit |
| Synergy Rx | brand | $947/mo | Visit |
| Vital Edge | brand | $990/mo | Visit |
| Josie | brand | $1,199/mo | Visit |
| RxSpan MD | brand | $1,349/mo | Visit |
| Trimrose | brand | $1,349/mo | Visit |
| Corsica Health | brand | $1,499/mo | Visit |
| RxION Health | brand | $1,499/mo | Visit |
| Astra | brand | $1,500/mo | Visit |
| Immortals | brand | $1,550/mo, prepaid | Visit |
| altRX | brand | $1,579/mo | Visit |
| DudeMeds | brand | $1,585/mo | Visit |
| HeliMeds | brand | $1,599/mo, prepaid | Visit |
| Effecty | brand | $1,600/mo | Visit |
| AlyveRx | brand | $1,695/mo | Visit |
| GobyMeds | brand | $1,695/mo | Visit |
| Elara Women's Wellness | brand | $1,697/mo | Visit |
| Eve | brand | $1,699/mo | Visit |
| Layla | brand | $1,699/mo | Visit |
| Tomorrow | brand | $1,699/mo | Visit |
| OrderlyMeds | brand | $1,839/mo | Visit |
| BiltRx | brand | $1,849/mo | Visit |
| myRocky | brand | $1,869/mo + program fee | Visit |
| Concierge MD LA | brand | $1,999/mo | Visit |
Wegovy Head-to-Head Comparisons
Short verdict pages setting Wegovy against the other GLP-1 options, working from the trial results, the dose ladders on each label, and what the manufacturers charge today.
See all drug-vs-drug verdicts.
Pivotal Wegovy Trial Walkthroughs
The trials that produced the Wegovy label, taken endpoint by endpoint, with the figures read off the source.
Wegovy Patient Questions, Answered
Questions people actually asked about Wegovy in named subreddits, each answered from the published trial data.
Wegovy Reference Cards
One-screen references for the dose schedule, what to do about a missed dose, and the side effects that warrant a call. Every figure checked against the DailyMed label.
Ranked PubMed Studies on Wegovy
The peer-reviewed studies on Wegovy and its neighbours that carry the most weight, gathered into lists. Every PMID was checked against PubMed esummary rather than recalled.
Related Research on Wegovy
Longer pieces written here, built on the trial papers themselves, checked against the FDA label, and argued rather than summarized.
Frequently Asked Questions
Sources & methodology — as of November 2026
- 1.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 2.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 3.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
- 4.SELECT Trial — Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (Lincoff AM et al.)— New England Journal of Medicine.PMID: 37952131.
- 5.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 6.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 7.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Ozempic · Drugs and brands
- GLP-1 receptor · Mechanism
- STEP-1 · Major trials
- SELECT · Major trials
- Titration · Dosing
- Ozempic face · Side effects